Chronic Kidney Disease: 68-Market Analysis and Sales Forecast
Summary
This report covers the 68 geographical markets and provides an Excel-based forecast model for the Chronic Kidney Disease (CKD) market through 2033.
Across the 68 markets, sales in the Chronic Kidney Disease market were $4 billion in 2023, growing to $26 billion in 2033.
The seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) represent approximately 55.5% and 52% of 68-market sales in 2023 and 2033, respectively.
Scope
- This publication is an expanded version of the Excel model containing the patient-based forecast sales for Chronic Kidney Disease (CKD), covered in GlobalData’s report “Chronic Kidney Disease: Seven -Market Drug Forecast and Market Analysis”, published in June 2024. In addition to patient based forecast sales data for the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan), this report contains sales forecast extrapolations for an additional 60 geographical markets (60M), totaling 68 markets (68M).
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the 7MM CKD therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 7MM CKD therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- About GlobalData
- 1 Executive Summary
- 1.1 Overview
- 1.2 68M summary statistics
- 1.3 Key 7MM events driving the 68M forecast extrapolation
- 2 Appendix
- 2.1 Abbreviations
- 2.2 Methodology
- 2.2.1 Patient-based forecast methodology
- 2.2.2 68M forecast extrapolation methodology
- 2.3 Primary research - key opinion leaders interviewed for this report
- 2.3.1 Key opinion leaders
- 2.4 Primary research - prescriber survey
- 2.5 About the authors
- 2.5.1 Analyst
- 2.5.2 Therapy area directors
- 2.5.3 Epidemiologist
- 2.5.4 Epidemiology reviewers
- 2.5.5 Vice President of Disease Intelligence and Epidemiology
- 2.5.6 Global Head and EVP of Healthcare Operations and Strategy
- Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook